Both in Pharmaceuticals
iBio vs Gain Therapeutics
Over the past year IBIO returned −47.7% and GANX returned −33.1%; their daily moves had a correlation of 0.19.
IBIO −47.7% GANX −33.1%Growth of $1, one year, split-adjusted
| Metric | IBIO | GANX |
|---|---|---|
| Price | $0.8000 | $1.11 |
| Market cap | $51.4M | $48.4M |
| Today | −2.85% | −3.48% |
| 1 month | −23.8% | −33.5% |
| 6 months | −54.8% | −41.9% |
| Year to date | −58.5% | −65.5% |
| 1 year | −54.5% | −39.7% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 514.5× | — |
| Net cash | $88.0M | $12.7M |
| Dividend yield | — | — |
| Volatility (60d) | 65.6% | 55.4% |
| Short % of float | 6.8% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).